tiprankstipranks
Trending News
More News >
Oruka Therapeutics (ORKA)
NASDAQ:ORKA
US Market

Oruka Therapeutics (ORKA) Income Statement

Compare
611 Followers

Oruka Therapeutics Income Statement

Last quarter (Q1 2025), Oruka Therapeutics's total revenue was $0.00, a decrease of ― from previous quarter. In Q1, Oruka Therapeutics's net income was $-21.00M. See Oruka Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -27.00K$ -91.00K$ -93.00K
Operating Expenses
$ 88.10M$ 19.24M$ 9.67M
Depreciation and Amortization
$ 27.00K$ 91.00K$ 93.00K
EBITDA
$ -82.23M$ -19.23M$ -9.64M
Operating Income
$ -88.12M$ -19.34M$ -9.77M
Other Income/Expenses
$ 4.40M$ 13.00K$ 19.00K
Pretax Income
$ -83.72M$ -19.32M$ -9.75M
Net Income
$ -83.72M$ -19.32M$ -9.74M
Per Share Metrics
Basic EPS
$ -4.99$ -16.68$ -8.40
Diluted EPS
$ -4.99$ -16.68$ -8.40
Weighted Average Shares Outstanding
16.79M 1.16M 1.16M
Weighted Average Shares Outstanding (Diluted)
16.79M 1.16M 1.16M
Currency in USD

Oruka Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis